Related Experiment Video

Updated: Jun 21, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

[Oncolytic virus therapy for malignant brain tumors]

Yasushi Ino1, Tomoki Todo

  • 1Department of Neurosurgery and Translational Research Center, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyoku, Tokyo 113 8655, Japan.

Brain and Nerve = Shinkei Kenkyu No Shinpo
|July 22, 2009
PubMed

Insights

Oncolytic virus therapy uses engineered viruses to selectively destroy tumor cells, offering a promising treatment for malignant brain tumors and other cancers with minimal side effects.

Area of Science:

  • Oncolytic virotherapy leverages genetically engineered or naturally attenuated viruses for targeted cancer treatment.
  • Focuses on selective tumor cell lysis, replication within cancer cells, and induction of antitumor immunity.

Context:

  • Malignant brain tumors, including recurrent malignant glioma, are a significant challenge in oncology.
  • Current treatment limitations necessitate novel therapeutic strategies.

Purpose:

  • To review recent clinical and preclinical advancements in oncolytic virus therapy for malignant brain tumors.
  • To highlight the safety, efficacy, and potential of oncolytic viruses in cancer treatment.

Summary:

  • Oncolytic viruses selectively infect and destroy tumor cells, sparing normal tissues.
  • Genetically engineered herpes simplex virus type 1 shows promise for malignant glioma due to high tumor selectivity and potency.
  • Intratumoral administration is the primary route, minimizing systemic adverse events, which are typically transient and flu-like.

Impact:

  • Oncolytic virus therapy presents a safe and potentially synergistic approach when combined with conventional cancer treatments.
  • Expands therapeutic options for various cancers beyond brain tumors, including melanoma, prostate, breast, head & neck, and colon cancers.
  • Advances in oncolytic virotherapy offer new hope for patients with difficult-to-treat malignancies.

More Related Videos

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...